This policy brief explores the dangerous potential of neuroweapons, the need for a “Neuroshield” to protect democracies from the risks of disinformation, the implications of brain-computer interfaces and other national security considerations related to brain health.
Harris A. Eyre, William Hynes, Geoffrey F. L. Ling, Jo-An Occhipinti, Rym Ayadi, Michael D. Matthews, Ryan Abbott, Patrick LoveAugust 10, 2023
Economic security has become a top priority for the West following the disruptions caused by COVID-19, the Russia-Ukraine war and the growing threat of China. Could investing in brain capital help build more resilient economies?
William Hynes, Paweł Świeboda, Patrick Love, Jo-An Occhipinti, Harris A. EyreAugust 2, 2023
Precision psychiatry promises to more accurately diagnose and treat patients. Brain health experts call for European researchers, policymakers and industry to work together to advance the field and give Europe a competitive edge.
Marion Leboyer, Paweł Świeboda, Harris A. Eyre, Veronique Briquet-LaugierJune 5, 2023
Brain diseases have profound impacts on our health, our communities and the economy. In this brief, fellow Harris A. Eyre explains why Texas needs to establish a state research institute to tackle a growing brain health crisis.
High cancer drug prices significantly contribute to health care costs in the United States, with the average annual price of new cancer drugs increasing from less than $10,000 before 2000 to $145,000 in 2015. Baker Institute fellows Hagop M. Kantarjian and Vivian Ho highlight this issue and propose possible solutions.
Repealing Obamacare and replacing it with market-based coverage that is both compassionate and prudent will make health care affordable again, which will guarantee access to insurance coverage for all Americans.